Allergan plc. (NYSE:AGN) : The consensus price target for Allergan plc. (NYSE:AGN) is $294.64 for the short term with a standard deviation of $51.4. The most optimist securities analyst among the 11 who monitor the stock believes that the stock can reach $400, however, the pessimist price target for the company is $232.
Allergan plc has lost 1.04% in the last five trading days and dropped 4.67% in the last 4 weeks. Allergan plc has dropped 13.8% during the last 3-month period . Year-to-Date the stock performance stands at -26.05%. Also, Piper Jaffray downgrades its view on Allergan plc. (NYSE:AGN) according to the research report released by the firm to its investors. The shares have now been rated Neutral by the stock experts at the ratings house. Earlier, the shares had a rating of Overweight. Piper Jaffray lowers the price target from $311 per share to $238 per share on Allergan plc.. The rating by the firm was issued on April 18, 2016.
Allergan plc. (NYSE:AGN) : 9 brokerage houses believe that Allergan plc. (NYSE:AGN) is a Strong Buy at current levels. 3 Analyst considers the fundamentals to be worthy of a Buy recommendation. 4 analysts believe that the current prices are in a balance with the stocks fundamentals, hence they propose Hold on Allergan plc. (NYSE:AGN). Zacks Investment Research suggests a Hold with a rank of 3. 1 analysts perceive the stock to be overvalued at the existing levels, hence their call is to Sell the stock.The median of all the 17 Wall Street Analysts endorse the stock as a Buy with a rating of 1.79.
Allergan plc. (NYSE:AGN): During Thursdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $230.99 and $227.00 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $231.71. The buying momentum continued till the end and the stock did not give up its gains. It closed at $231.09, notching a gain of 0.23% for the day. The total traded volume was 2,849,007 . The stock had closed at $230.55 on the previous day.
In an insider trading activity, Hilado Maria Teresa, CFO of Allergan Plc, executed a transaction worth $159,678 on June 2, 2016. A total of 661 shares were purchased at an average price of $241.57. The Insider information was divulged by the Securities and Exchange Commission in a Form 4 filing. The information is based on open market trades at the market prices.Option exercises are not covered.